Posted by Michael Wonder on 12 Oct 2022
Thousands could be affected by shortage of diabetes drug
12 October 2022 - Thousands of people with type 2 diabetes could be affected by a shortage of the drug dulaglutide.
Manufacturer Lilly has instructed New Zealand health care providers to consider not prescribing Trulicity (dulaglutide) to new patients due to a lack of supply.
